PTC Long Term Debt from 2010 to 2024

PTCT Stock  USD 45.11  0.90  1.96%   
PTC Therapeutics Long Term Debt yearly trend continues to be comparatively stable with very little volatility. Long Term Debt is likely to outpace its year average in 2024. Long Term Debt is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. View All Fundamentals
 
Long Term Debt  
First Reported
2004-12-31
Previous Quarter
284.8 M
Current Value
285.1 M
Quarterly Volatility
294.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PTC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PTC Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 135.6 M, Total Revenue of 984.7 M or Research Development of 699.9 M, as well as many indicators such as Price To Sales Ratio of 2.09, Dividend Yield of 0.0 or Days Sales Outstanding of 51.74. PTC financial statements analysis is a perfect complement when working with PTC Therapeutics Valuation or Volatility modules.
  
Check out the analysis of PTC Therapeutics Correlation against competitors.
For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.

Latest PTC Therapeutics' Long Term Debt Growth Pattern

Below is the plot of the Long Term Debt of PTC Therapeutics over the last few years. Long-term debt is a debt that PTC Therapeutics has held for over one year. Long-term debt appears on PTC Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on PTC Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. PTC Therapeutics' Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PTC Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Long Term Debt10 Years Trend
Slightly volatile
   Long Term Debt   
       Timeline  

PTC Long Term Debt Regression Statistics

Arithmetic Mean389,609,787
Geometric Mean0.00
Coefficient Of Variation167.93
Mean Deviation440,811,259
Median141,347,000
Standard Deviation654,267,059
Sample Variance428065.4T
Range2B
R-Value0.75
Mean Square Error201347.3T
R-Squared0.56
Significance0
Slope109,795,274
Total Sum of Squares5992915.4T

PTC Long Term Debt History

2024B
20231.9 B
2022571.7 M
2021281.9 M
2020309.1 M
2019293.9 M
2018141.3 M

Other Fundumenentals of PTC Therapeutics

PTC Therapeutics Long Term Debt component correlations

About PTC Therapeutics Financial Statements

PTC Therapeutics shareholders use historical fundamental indicators, such as Long Term Debt, to determine how well the company is positioned to perform in the future. Although PTC Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in PTC Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on PTC Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Long Term Debt1.9 BB
Short and Long Term Debt Total2.2 B2.3 B
Long Term Debt Total657.5 M690.4 M
Short and Long Term Debt194.3 M107.6 M
Long Term Debt To Capitalization 1.75  1.84 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for PTC Stock Analysis

When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.